Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP505993.RAAp66v7oggR9v36ABJ4W5r-WT3KH8AtM0LGq6A8N5Q1M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505993.RAAp66v7oggR9v36ABJ4W5r-WT3KH8AtM0LGq6A8N5Q1M130_assertion type Assertion NP505993.RAAp66v7oggR9v36ABJ4W5r-WT3KH8AtM0LGq6A8N5Q1M130_head.
- NP505993.RAAp66v7oggR9v36ABJ4W5r-WT3KH8AtM0LGq6A8N5Q1M130_assertion description "[HER-2/neu-dependent differential expression of PGK1, FASN, Hsp27, and GLO was further validated in four breast cancer cell lines and 12 breast tumors by immunoblotting and confirmed by partially switching off the HER-2/neu signaling in the high HER-2/neu-expressing SKBr3 cell line with Herceptin treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505993.RAAp66v7oggR9v36ABJ4W5r-WT3KH8AtM0LGq6A8N5Q1M130_provenance.
- NP505993.RAAp66v7oggR9v36ABJ4W5r-WT3KH8AtM0LGq6A8N5Q1M130_assertion evidence source_evidence_literature NP505993.RAAp66v7oggR9v36ABJ4W5r-WT3KH8AtM0LGq6A8N5Q1M130_provenance.
- NP505993.RAAp66v7oggR9v36ABJ4W5r-WT3KH8AtM0LGq6A8N5Q1M130_assertion SIO_000772 16048908 NP505993.RAAp66v7oggR9v36ABJ4W5r-WT3KH8AtM0LGq6A8N5Q1M130_provenance.
- NP505993.RAAp66v7oggR9v36ABJ4W5r-WT3KH8AtM0LGq6A8N5Q1M130_assertion wasDerivedFrom befree-2016 NP505993.RAAp66v7oggR9v36ABJ4W5r-WT3KH8AtM0LGq6A8N5Q1M130_provenance.
- NP505993.RAAp66v7oggR9v36ABJ4W5r-WT3KH8AtM0LGq6A8N5Q1M130_assertion wasGeneratedBy ECO_0000203 NP505993.RAAp66v7oggR9v36ABJ4W5r-WT3KH8AtM0LGq6A8N5Q1M130_provenance.